AR and prostate cancer: SHR2554 alone or in combination with SHR3680 (a novel AR-antagonist) in patients with metastatic Castration Resistant Prostate CancerSHR2554 in combination with HRS-5041 (a novel AR-antagonist) in patients with advanced Prostate Cancer